Back

Attenuation of medial arterial calcification by senescent vascular smooth muscle cell clearance: a uPAR-targeted senolytic therapy

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Mechanistic insights into aortic diseases Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Mingxuan Zhang

The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen (China)

6 More presentations in this session

Presentation thumbnail
Hyperuricemia activates the TLR2–MAPK signaling axis in vascular macrophages to drive aortic dissection
Mr B. Zheng (Shenzhen, CN)
Abstract Slides
Presentation thumbnail
Beyond chronological age: identifying accelerated aortic aging through laboratory indicators and geometric phenotyping
Doctor X. Duan (Kunming, CN)
Abstract Slides
Presentation thumbnail
Pharmacological inhibition of microplastic uptake prevents endothelial injury
Doctor G. Tortorella (Naples, IT)
Abstract Slides
Presentation thumbnail
Pyruvate dehydrogenase kinase 4 Triggers VSMCs phenotype switching and aortic aneurysm/dissection by regulating NLRP3 lactylation
Associate Professor D. Yang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
GPR18 plays an atheroprotective role by regulating humoral and effector T-cell responses
Mrs A. Prabhu (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Mechanistic insights into aortic diseases

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Cellular mechanisms of aortic valve calcification in primary human valvular interstitial cell culture
3 September 2019
thumbnail
Congress Presentation
The functional role of TOP2beta PARylation in myeloid cells senescence-associated secretory phenotype (SASP) and atherosclerosis induction following ionizing radiation
20 June 2025
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V
5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources